The Angiotensin-Converting Enzyme Inhibitor Captopril Inhibits Poly(Adp-Ribose) Polymerase Activation and Exerts Beneficial Effects in an Ovine Model of Burn and Smoke Injury-Reference-Cited by-同舟云学术

The Angiotensin-Converting Enzyme Inhibitor Captopril Inhibits Poly(Adp-Ribose) Polymerase Activation and Exerts Beneficial Effects in an Ovine Model of Burn and Smoke Injury

Published:2011-10 Issue:4 Volume:36 Page:402-409
ISSN:1073-2322
Container-title:Shock
language:en
Short-container-title:

Author:

Asmussen Sven,Bartha Eva,Olah Gabor,Sbrana Elena,Rehberg Sebastian W.,Yamamoto Yusuke,Enkhbaatar Perenlei,Hawkins Hal K.,Ito Hiroshi,Cox Robert A.,Traber Lillian D.,Traber Daniel L.,Szabo Csaba

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine,Emergency Medicine

Reference26 articles.

1. Pathophysiology of acute lung injury in combined burn and smoke inhalation injury.;Enkhbaatar;Clin Sci (Lond),2004

2. The involvement of free radicals in burn injury: a review.;Latha;Burns,2001

3. Tocopherol as treatment for lung injury associated with burn and smoke inhalation.;Traber;J Burn Care Res,2009

4. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors.;Jagtap;Nat Rev Drug Discov,2005

5. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.;Pacher;Am J Pathol,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different therapeutic associations of renin-angiotensin system inhibitors with coronavirus disease 2019 compared with usual pneumonia;The Korean Journal of Internal Medicine;2021-05-01

2. Renin-angiotensin system at the interface of COVID-19 infection;European Journal of Pharmacology;2021-01

Role of Renin-Angiotensin System in Acute Lung Injury Caused by Viral Infection

;Infection and Drug Resistance;2020-10

4. Renin-angiotensin-system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation;Pulmonary Pharmacology & Therapeutics;2019-10

5. The clinically used PARP inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury;British Journal of Pharmacology;2017-03-05